Page last updated: 2024-09-04

perifosine and ER-Negative PR-Negative HER2-Negative Breast Cancer

perifosine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, Y; Huang, J; Kim, W; Lee, S; Liu, J; Lou, Z; Luo, K; Nowsheen, S; Song, Z; Tu, X; Yuan, J; Zhou, Q	1
Buchholz, S; Engel, JB; Kwok, CW; Ortmann, O; Seitz, S; Treeck, O	1

Other Studies

2 other study(ies) available for perifosine and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
A novel UCHL Cell death & disease, 2019, 05-21, Volume: 10, Issue:6 Topics: Animals; Antineoplastic Agents; Apoptosis; BRCA2 Protein; Cell Line, Tumor; Female; Humans; Mice; Mice, Nude; Phosphorylcholine; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Rad51 Recombinase; Radiation, Ionizing; Recombinational DNA Repair; RNA, Guide, Kinetoplastida; Transplantation, Heterologous; Triple Negative Breast Neoplasms; Ubiquitin Thiolesterase; Ubiquitination	2019
Receptors for luteinizing hormone-releasing hormone (GnRH) as therapeutic targets in triple negative breast cancers (TNBC). Targeted oncology, 2015, Volume: 10, Issue:3 Topics: Aniline Compounds; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA Mutational Analysis; Dose-Response Relationship, Drug; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Gonadotropin-Releasing Hormone; Humans; Phosphatidylinositol 3-Kinases; Phosphorylcholine; Receptors, LHRH; Triple Negative Breast Neoplasms; Triptorelin Pamoate	2015

Article

Year

A novel UCHL

Cell death & disease, 2019, 05-21, Volume: 10, Issue:6

Topics: Animals; Antineoplastic Agents; Apoptosis; BRCA2 Protein; Cell Line, Tumor; Female; Humans; Mice; Mice, Nude; Phosphorylcholine; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Rad51 Recombinase; Radiation, Ionizing; Recombinational DNA Repair; RNA, Guide, Kinetoplastida; Transplantation, Heterologous; Triple Negative Breast Neoplasms; Ubiquitin Thiolesterase; Ubiquitination

2019

Receptors for luteinizing hormone-releasing hormone (GnRH) as therapeutic targets in triple negative breast cancers (TNBC).

Targeted oncology, 2015, Volume: 10, Issue:3

Topics: Aniline Compounds; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA Mutational Analysis; Dose-Response Relationship, Drug; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Gonadotropin-Releasing Hormone; Humans; Phosphatidylinositol 3-Kinases; Phosphorylcholine; Receptors, LHRH; Triple Negative Breast Neoplasms; Triptorelin Pamoate

2015